MMSI Merit Medical Systems
- 83.330
- +0.930+1.13%
Merit Medical Systems News
Merit Medical Expands Embolics Portfolio With New Siege Vascular Plug and Bearing NsPVA Express Prefilled Syringe
New products broaden Merit's leadership in embolotherapy.Full portfolio will be exhibited at the 18th Annual GEST Meeting May 16-19 in New York City. SOUTH JORDAN, Utah, May 14, 2024 (GLOBE NEWSWIRE) -- Merit
We Think Merit Medical Systems (NASDAQ:MMSI) Can Manage Its Debt With Ease
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
Merit Medical Is Maintained at Buy by Canaccord Genuity
Merit Medical Is Maintained at Buy by Canaccord Genuity
Merit Medical Price Target Cut to $102.00/Share From $112.00 by Canaccord Genuity
Merit Medical Price Target Cut to $102.00/Share From $112.00 by Canaccord Genuity
The Analyst Landscape: 11 Takes On Merit Medical Systems
Merit Medical Systems (NASDAQ:MMSI) has been analyzed by 11 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise over
Barrington Research: Maintaining the Merit Medical Systems (MMSI.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $98.00 to $100.00.
Barrington Research: Maintaining the Merit Medical Systems (MMSI.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $98.00 to $100.00.
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2024 Earnings Call Transcript
Barrington Raises Adjusts Price Target on Merit Medical Systems to $100 From $98, Maintains Outperform Rating
Merit Medical Systems (MMSI) has an average rating of outperform and price targets ranging from $80 to $112, according to analysts polled by Capital IQ.
Bank of America Securities Keeps Their Hold Rating on Merit Medical Systems (MMSI)
Merit Medical Price Target Cut to $85.00/Share From $88.00 by Needham
Merit Medical Price Target Cut to $85.00/Share From $88.00 by Needham
Merit Medical Is Maintained at Buy by Needham
Merit Medical Is Maintained at Buy by Needham
Needham Maintains Buy on Merit Medical Systems, Lowers Price Target to $85
Needham analyst Mike Matson maintains Merit Medical Systems (NASDAQ:MMSI) with a Buy and lowers the price target from $88 to $85.
Merit Medical Systems Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/01/2024 14.71% Needham $88 → $85 Maintains Buy 04/16/2024 32.25% Barrington Research $98 → $98 Maintain
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Inari Medical (NARI) and Tenet Healthcare (THC)
Maintaining Hold: Balancing Merit Medical Systems' Strong Q1 Performance With a Cautious 2024 Outlook
Earnings Call Summary | Merit Medical Systems(MMSI.US) Q1 2024 Earnings Conference
The following is a summary of the Merit Medical Systems, Inc. (MMSI) Q1 2024 Earnings Call Transcript:Financial Performance:Merit Medical Systems reported Q1 revenue of $323.5 million, an 8.7% increas
Merit Medical Systems Inc (MMSI) Q1 2024 Earnings Call Transcript Highlights: Strong ...
Merit Medical Systems Inc. Surpasses Q1 Revenue Expectations and Boosts Profitability
GUIDANCE: (MMSI) MERIT MEDICAL SYSTEMS Sees Fiscal Year 2024 EPS Range $3.28 - $3.35
04:28 PM EDT, 04/30/2024 (MT Newswires) -- GUIDANCE: (MMSI) MERIT MEDICAL SYSTEMS Sees Fiscal Year 2024 EPS Range $3.28 - $3.35
Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 Revenue $323.5M, Vs. Street Est of $315.9M
04:28 PM EDT, 04/30/2024 (MT Newswires) -- Earnings Flash (MMSI) MERIT MEDICAL SYSTEMS Reports Q1 Revenue $323.5M, vs. Street Est of $315.9M
Analysis
Price Target
No Data
